Abstract
The skin presents several advantages as an administration route, including the possibility of localizing drugs in the tissue and overcoming the first-pass effect. However, its use is limited by the barrier function of the tissue, which is provided mainly (but not exclusively) by the stratum corneum. Various strategies to overcome this layer, have been considered over the years, ranging from the use of physical methods such as iontophoresis to wellknown conventional chemical penetration enhancers like oleic acid and DMSO. However, delivery of hydrophilic and large compounds remains a challenge. More recently, selected groups of peptides have attracted increasing attention due to their ability to penetrate into the skin promoting the transport of small and large molecules, including nanodispersed systems. Here, we will discuss the properties and application to cutaneous (into the skin) and transdermal (across the skin) delivery of three groups of peptides, namely protein-transduction domains, phagedisplayed peptides and antimicrobial peptides.
Keywords: Protein transduction domain, cell penetrating peptides, skin, transdermal delivery, topical.
Current Pharmaceutical Design
Title:Potential of Peptide-Based Enhancers for Transdermal Delivery
Volume: 21 Issue: 20
Author(s): Luciana B. Lopes, Vanessa F.M. Carvalho and Debora P. de Lemos
Affiliation:
Keywords: Protein transduction domain, cell penetrating peptides, skin, transdermal delivery, topical.
Abstract: The skin presents several advantages as an administration route, including the possibility of localizing drugs in the tissue and overcoming the first-pass effect. However, its use is limited by the barrier function of the tissue, which is provided mainly (but not exclusively) by the stratum corneum. Various strategies to overcome this layer, have been considered over the years, ranging from the use of physical methods such as iontophoresis to wellknown conventional chemical penetration enhancers like oleic acid and DMSO. However, delivery of hydrophilic and large compounds remains a challenge. More recently, selected groups of peptides have attracted increasing attention due to their ability to penetrate into the skin promoting the transport of small and large molecules, including nanodispersed systems. Here, we will discuss the properties and application to cutaneous (into the skin) and transdermal (across the skin) delivery of three groups of peptides, namely protein-transduction domains, phagedisplayed peptides and antimicrobial peptides.
Export Options
About this article
Cite this article as:
Lopes B. Luciana, Carvalho F.M. Vanessa and de Lemos P. Debora, Potential of Peptide-Based Enhancers for Transdermal Delivery, Current Pharmaceutical Design 2015; 21 (20) . https://dx.doi.org/10.2174/1381612821666150428143243
DOI https://dx.doi.org/10.2174/1381612821666150428143243 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Therapy of Cushings Syndrome: Drugs and Indications
Mini-Reviews in Medicinal Chemistry MicroRNAs and Diabetes Mellitus Type 1
Current Diabetes Reviews New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Clinical Importance of Calcium-Sensing Receptor Gene Polymorphism Arg990Gly in the Age of Calcimimetic Therapy
Current Pharmacogenomics Metabolism in the Tumor Microenvironment: What is Known about Stromal and Immune Cells?
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells
Anti-Cancer Agents in Medicinal Chemistry Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Low Birth Weight and Risk of Obesity - A Potential Problem for the Japanese People
Current Women`s Health Reviews Role of C1858T Polymorphism of Lymphoid Tyrosine Phosphatase in Egyptian Children and Adolescents with Type 1 Diabetes
Current Diabetes Reviews Purinergic Signalling and Endothelium
Current Vascular Pharmacology Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews Peri-Procedural Care of Renal Nerve Ablation Candidates
Current Clinical Pharmacology Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)
Current Pharmaceutical Design T-type Ca Channel Blockers in Patients with Chronic Kidney Disease in Clinical Practice
Current Hypertension Reviews Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Inflammation, Adiponectin, Obesity and Cardiovascular Risk
Current Medicinal Chemistry Tardive Dyskinesia with Atypical Antipsychotic Drugs
Current Drug Therapy Model Checking a Synchronous Diabetes-Cancer Logical Network
Current Bioinformatics